| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 30.44▼ | 30.44▼ | 30.44▼ | 29.65▲ | 29.75▲ |
| MA10 | 30.31▼ | 30.31▼ | 30.31▼ | 29.41▲ | 29.62▲ |
| MA20 | 29.91▲ | 29.90▲ | 29.89▲ | 29.75▲ | 28.85▲ |
| MA50 | 29.21▲ | 28.81▲ | 28.72▲ | 29.70▲ | 26.67▲ |
| MA100 | 27.88▲ | 27.01▲ | 26.67▲ | 28.82▲ | N/A |
| MA200 | N/A | N/A | N/A | 26.82▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | -0.016▼ | -0.025▼ | 0.034▲ | -0.013▼ |
| RSI | 61.584▲ | 62.845▲ | 63.385▲ | 56.876▲ | 63.445▲ |
| STOCH | 82.825▲ | 82.832▲ | 82.832▲ | 60.153 | 61.261 |
| WILL %R | -27.500 | -26.829 | -26.829 | -8.709▲ | -18.631▲ |
| CCI | 24.434 | 25.297 | 25.297 | 86.155 | 66.938 |
|
Monday, November 03, 2025 09:05 AM
(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool. The drugmaker said 99.36% ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/11/25 | 30.00 | 30.1845 | 30.00 | 30.1845 | 2,292 |
| 26/11/25 | 29.97 | 30.06 | 29.888 | 30.028 | 3,700 |
| 25/11/25 | 29.35 | 29.73 | 29.35 | 29.73 | 8,200 |
| 24/11/25 | 29.21 | 29.52 | 29.21 | 29.515 | 3,500 |
| 21/11/25 | 28.7632 | 29.087 | 28.747 | 28.7959 | 6,246 |
| 20/11/25 | 29.80 | 29.80 | 28.5755 | 28.5755 | 5,074 |
| 19/11/25 | 29.40 | 29.42 | 29.153 | 29.24 | 8,800 |
| 18/11/25 | 28.85 | 29.24 | 28.85 | 29.0538 | 3,968 |
| 17/11/25 | 29.5832 | 29.5874 | 29.18 | 29.3125 | 44,196 |
| 14/11/25 | 29.74 | 29.74 | 29.62 | 29.62 | 589 |
|
|
||||
|
|
||||
|
|